<DOC>
	<DOCNO>NCT00626860</DOCNO>
	<brief_summary>This study aim determine vacccine use safely patient advance melanoma ( cancer pigment cell ) whether cell vaccine capabale produce immune response cancer .</brief_summary>
	<brief_title>The Use Dendritic Cell/Tumor Hybridomas Novel Tumor Vaccine Patients With Advance Melanoma</brief_title>
	<detailed_description>To assess toxicity associate vaccination melanoma patient dendritic cell ( DC ) /tumor fusion . To determine cellular humoral immunity induce serial vaccination DC/tumor fusion cell . To determine vaccination DC/tumor fusion result tumor response .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>patient confirm diagnosis disseminate melanoma , measurable clearly progressive metastatic involevment Patients must least 18 year old Patients must ECOG performance status 01 great 9 week life expectancy Those patient follow accessible tumor eligible : soft tissue , bone marrow visceral lesion ; Skin superficial soft tissue , lymph node amenable resection local anesthesia ; Patients require surgical procedure consider significantly invasive may require general anesthesia , thorascopic biopsy , laparascopic biopsy mediastinal node biopsy may potentially eligible ; Malignant ascites pleural effusion ; Patients require major surgical intervention consider ineligible . Patients schedule undergo tumor resection independent diagnostic therapeutic indication may tumor collected purpose study . Labs : WBC &gt; _ 2.0 x 10x3/uL , Bilirubin &lt; _2.0 mg/dL , Creatine &lt; _ 2.0mg/dL Women childbearing age must negative pregnancy test adequate contraception method ( ) must document All patient must inform investigational nature study must give write informed consent accordance institutional federal guideline Patients must receive immunotherapy treatment past four week prior study entry Patients must receive chemotherapy three week prior first vaccination Patients must without evidence active CNS disease Patients must clinically significant autoimmune disease Patients must HIV negative Patients must serious intercurrent illness infection require IV antibiotic , significant cardiac disease characterize significant arrhythmia , ischemic coronary disease congestive heart failure Patients require corticosteroid either melanoma related comorbid illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>melanoma</keyword>
</DOC>